| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement M Dominici, K Le Blanc, I Mueller, I Slaper-Cortenbach, FC Marini, ... Cytotherapy 8 (4), 315-317, 2006 | 20792 | 2006 |
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo A Bartholomew, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, ... Experimental hematology 30 (1), 42-48, 2002 | 3294 | 2002 |
| Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement EM Horwitz, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, ... Cytotherapy 7 (5), 393-395, 2005 | 2491 | 2005 |
| Mesenchymal stem cells: biology and potential clinical uses RJ Deans, AB Moseley Experimental hematology 28 (8), 875-884, 2000 | 2454 | 2000 |
| Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep KW Liechty, TC MacKenzie, AF Shaaban, A Radu, AMB Moseley, ... Nature medicine 6 (11), 1282-1286, 2000 | 1803 | 2000 |
| Defining protective responses to pathogens: cytokine profiles in leprosy lesions M Yamamura, K Uyemura, RJ Deans, K Weinberg, TH Rea, BR Bloom, ... Science 254 (5029), 277-279, 1991 | 1561 | 1991 |
| T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression E Klyushnenkova, JD Mosca, V Zernetkina, MK Majumdar, KJ Beggs, ... Journal of biomedical science 12, 47-57, 2005 | 802 | 2005 |
| Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. M Linker-Israeli, RJ Deans, DJ Wallace, J Prehn, T Ozeri-Chen, ... Journal of immunology (Baltimore, Md.: 1950) 147 (1), 117-123, 1991 | 720 | 1991 |
| Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion SM Devine, AM Bartholomew, N Mahmud, M Nelson, S Patil, W Hardy, ... Experimental hematology 29 (2), 244-255, 2001 | 637 | 2001 |
| International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans, J DeBruijn, ... Cytotherapy 18 (2), 151-159, 2016 | 487 | 2016 |
| International Society for Cellular Therapy. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement EM Horwitz, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, ... Cytotherapy 7 (5), 393-395, 2005 | 412 | 2005 |
| Stem cell therapy as an emerging paradigm for stroke (STEPS) II SI Savitz, M Chopp, R Deans, ST Carmichael, D Phinney, L Wechsler Stroke 42 (3), 825-829, 2011 | 312 | 2011 |
| Bioenergetic and functional consequences of bone marrow–derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling L Zeng, Q Hu, X Wang, A Mansoor, J Lee, J Feygin, G Zhang, ... Circulation 115 (14), 1866-1875, 2007 | 287 | 2007 |
| Specific interaction between coronavirus leader RNA and nucleocapsid protein SA Stohlman, RS Baric, GN Nelson, LH Soe, LM Welter, RJ Deans Journal of virology 62 (11), 4288-4295, 1988 | 274 | 1988 |
| Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription RS Baric, GW Nelson, JO Fleming, RJ Deans, JG Keck, N Casteel, ... Journal of virology 62 (11), 4280-4287, 1988 | 250 | 1988 |
| Baboon Mesenchymal Stem Cells Can Be Genetically Modified to Secrete Human Erythropoietin In Vivo A Bartholomew, S Patil, A Mackay, M Nelson, D Buyaner, W Hardy, ... Human gene therapy 12 (12), 1527-1541, 2001 | 222 | 2001 |
| Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury SA Busch, JA Hamilton, KP Horn, FX Cuascut, R Cutrone, N Lehman, ... Journal of neuroscience 31 (3), 944-953, 2011 | 169 | 2011 |
| EcoRI analysis of bacteriophage P22 DNA packaging EN Jackson, DA Jackson, RJ Deans Journal of Molecular Biology 118 (3), 365-388, 1978 | 165 | 1978 |
| Biomanufacturing for clinically advanced cell therapies A Aijaz, M Li, D Smith, D Khong, C LeBlon, OS Fenton, RM Olabisi, ... Nature biomedical engineering 2 (6), 362-376, 2018 | 162 | 2018 |
| Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes PA Walker, SK Shah, F Jimenez, MH Gerber, H Xue, R Cutrone, ... Experimental neurology 225 (2), 341-352, 2010 | 156 | 2010 |
